Division of Rheumatology, Department of Internal Medicine, Nagoya City University Hospital, and Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Department of Rheumatology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Int J Rheum Dis. 2022 Aug;25(8):897-909. doi: 10.1111/1756-185X.14365. Epub 2022 Jun 9.
To investigate the impact of dysphagia on long-term survival and swallowing function outcomes in patients with idiopathic inflammatory myopathy other than inclusion body myositis.
We retrospectively evaluated consecutive patients with idiopathic inflammatory myopathy other than inclusion body myositis to investigate the impact of dysphagia and its severity assessed using the Food Intake LEVEL Scale on survival and swallowing function outcomes. Time-to-event analyses were used, including Kaplan-Meier curves with log-rank (trend) test, cumulative incidence with Gray's test, and Cox proportional hazards models.
Of the 254 patients, 26 were dysphagic, including eight severe (Food Intake LEVEL Scale [FILS] score 2, 3) and six most severe (FILS score 1) cases; 210 were non-dysphagic, and 18 were indeterminate cases. During the 5 years after myositis diagnosis, 15 (57.7%) dysphagic and 31 (14.8%) non-dysphagic patients died, and dysphagic patients had significantly shorter survival. However, multivariate analysis showed that shorter survival was significantly associated with baseline age-adjusted Charlson Comorbidity Index (hazard ratio [HR] 1.57, 95% confidence interval [CI] 1.36-1.82]), but not with dysphagia (HR 1.46, 95% CI 0.69-3.10). Dysphagia severity was significantly associated with delayed recovery of dysphagia. In 20 non-severe or severe dysphagic cases, 19 restored swallowing function within 1 year. The most severe cases had a significantly higher cumulative probability of death before recovery from dysphagia than severe cases.
The poor survival of dysphagic myositis patients was largely confounded by advanced age and comorbid malignancies. However, patients with the most severe dysphagia had a significantly worse swallowing function and survival prognosis than those with milder dysphagia.
研究特发性炎性肌病(非包涵体肌炎)患者吞咽困难对长期生存和吞咽功能结局的影响。
我们回顾性评估了连续的特发性炎性肌病(非包涵体肌炎)患者,以研究吞咽困难及其严重程度(使用饮食摄入水平量表评估)对生存和吞咽功能结局的影响。使用时间事件分析,包括 Kaplan-Meier 曲线和对数秩(趋势)检验、累积发生率和 Gray 检验以及 Cox 比例风险模型。
在 254 例患者中,26 例存在吞咽困难,包括 8 例严重(饮食摄入水平量表评分 2、3)和 6 例最严重(饮食摄入水平量表评分 1)病例;210 例无吞咽困难,18 例为不确定病例。在肌炎诊断后的 5 年内,15 例(57.7%)吞咽困难和 31 例(14.8%)无吞咽困难患者死亡,且吞咽困难患者的生存时间显著缩短。然而,多变量分析显示,较短的生存时间与基线年龄调整 Charlson 合并症指数显著相关(风险比 [HR] 1.57,95%置信区间 [CI] 1.36-1.82),但与吞咽困难无关(HR 1.46,95% CI 0.69-3.10)。吞咽困难的严重程度与吞咽困难的延迟恢复显著相关。在 20 例非严重或严重吞咽困难的病例中,19 例在 1 年内恢复吞咽功能。最严重的病例在吞咽困难恢复前死亡的累积概率明显高于严重病例。
吞咽困难肌炎患者的不良生存主要是由高龄和合并恶性肿瘤引起的。然而,吞咽困难最严重的患者的吞咽功能和生存预后明显差于吞咽困难较轻的患者。